Skip to the page

Data / Drug companies / Baxter Healthcare Corporation

Baxter Healthcare Corporation: 52 products in the FDA NDC directory, labeler code 43066

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Baxter Healthcare Corporation (labeler code 43066) lists 52 products in the FDA National Drug Code Directory, covering 22 finished drugs by generic name. By type: 52 prescription drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on September 18, 2026.

The request: Watch Baxter Healthcare Corporation (FDA labeler code 43066): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
43066
Products in commercial distribution
52
Packages
52
Finished drugs by generic name
22
Prescription products
52
Over the counter products
0
Controlled substance products
Schedule III 1, Schedule IV 2
Flagged as original packager
46 of 46 products that carry the flag
Started marketing in the last 12 months
13
Earliest marketing start
January 30, 1992
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)3873.1%
New drug applications (NDA)1426.9%

Products by type

TypeProductsShare
Prescription drugs52100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Injection, solution3159.6%
Injection1834.6%
Injection, solution, concentrate23.8%
Injection, emulsion11.9%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Rocuronium Bromide43066-509Injection, solutionGeneric drugs (ANDA)September 18, 2026
Rocuronium Bromide43066-507Injection, solutionGeneric drugs (ANDA)September 18, 2026
Diazepam43066-123Injection, solutionGeneric drugs (ANDA)July 28, 2026
Diazepam43066-121Injection, solutionGeneric drugs (ANDA)July 28, 2026
Ketorolac tromethamine43066-053Injection, solutionGeneric drugs (ANDA)May 19, 2026
Ketorolac tromethamine43066-051Injection, solutionGeneric drugs (ANDA)May 19, 2026
Ketorolac tromethamine43066-049Injection, solutionGeneric drugs (ANDA)May 19, 2026
Epinephrine43066-803Injection, solution, concentrateNew drug applications (NDA)March 30, 2026
Epinephrine43066-801Injection, solution, concentrateNew drug applications (NDA)March 30, 2026
Phytonadione43066-132Injection, emulsionGeneric drugs (ANDA)February 26, 2026
Docetaxel43066-048InjectionGeneric drugs (ANDA)November 27, 2025
Docetaxel43066-046InjectionGeneric drugs (ANDA)November 27, 2025
Docetaxel43066-044InjectionGeneric drugs (ANDA)November 27, 2025
Ketamine hydrochloride43066-117InjectionGeneric drugs (ANDA)September 17, 2025
Hydralazine hydrochloride43066-041InjectionGeneric drugs (ANDA)July 17, 2025
Naloxone hydrochloride43066-142Injection, solutionGeneric drugs (ANDA)June 3, 2025
Succinylcholine chloride43066-129Injection, solutionGeneric drugs (ANDA)September 24, 2024
Succinylcholine chloride43066-127Injection, solutionGeneric drugs (ANDA)September 24, 2024
Ropivacaine hydrochloride43066-154Injection, solutionGeneric drugs (ANDA)January 1, 2024
Ropivacaine hydrochloride43066-152Injection, solutionGeneric drugs (ANDA)January 1, 2024
Foscarnet sodium43066-089Injection, solutionGeneric drugs (ANDA)August 28, 2023
Norepinephrine Bitartrate43066-997InjectionGeneric drugs (ANDA)May 6, 2021
Prochlorperazine edisylate43066-090InjectionGeneric drugs (ANDA)May 3, 2021
Tranexamic acid43066-008InjectionGeneric drugs (ANDA)July 1, 2020
Ropivacaine hydrochloride43066-027InjectionGeneric drugs (ANDA)April 9, 2020

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.